[Skip to Navigation]
October 1976

Human Conjunctivitis: II. Treatment

Author Affiliations

From the Department of Ophthalmology, Boston City Hospital and Boston University Medical Center (Drs Leibowitz, Pratt, Flagstad, and Berrospi), and the Surgical Bacteriology Laboratory, Peter Bent Brigham Hospital, Boston (Dr Kundsin).

Arch Ophthalmol. 1976;94(10):1752-1756. doi:10.1001/archopht.1976.03910040526011

• One hundred forty-three patients (207 eyes) with conjunctivitis or blepharoconjunctivitis were investigated to determine (1) the safety of topical corticosteroid therapy and the relative efficacy of formulations of increasing potency and (2) the effectiveness of a steroid-antibiotic preparation compared to each of its components alone and to a placebo.

The corticosteroids were equally effective in suppressing conjunctival inflammation; all were more effective than the placebo. Active conjunctivitis was controlled more readily by those preparations containing a steroid, both alone and in combination. The corticosteroid alone (dexamethasone) was more effective in producing inactivation of conjunctivitis than the antibiotic alone (a mixture of neomycin sulfate and polymyxin B sulfate). This observation remained unchanged when cases of Staphylococcus aureus conjunctivitis were analyzed separately.

No serious complications resulted from any treatment regimen.

Add or change institution